However, recent studies indicate that the risks reported by Kuchenbaecker et al. may overestimate those for pathogenic BRCA2 variant carriers: Current data show a cumulative breast cancer risk of 58% to age 80 years and the lifetime risk of ovarian cancer is also considered to be lower than previously assumed [15, 16]. Here, BRCA2 is linked to breast cancer.